36C24122Q0045.docx

DOCX document 57 KB Posted

Attached to
6515--Intent to Sole Source - Synergy XD Heart Stents
Solicitation number
36C24122Q0045
Issued by

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

VHAPM Part 813.106 Simplified Acquisition Procedures: Soliciting from a Single Source Attachment 1: Single Source Justification for SAP under the SAT

SUBJECT*
Intent to Sole Source - Synergy XD Heart Stents

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
02908
SOLICITATION NUMBER*
36C24122Q0045
RESPONSE DATE/TIME/ZONE
11-04-2021 12:00 EASTERN TIME, NEW YORK, USA
ARCHIVE
30 DAYS AFTER THE RESPONSE DATE

SET-ASIDE

PRODUCT SERVICE CODE*
6515
NAICS CODE*
339112
PLACE OF PERFORMANCE
Boston Healthcare System

West Roxbury VAMC

Cardiology

1400 VFW Parkway

West Roxbury MA

POSTAL CODE
02132-4927
COUNTRY
USA

CONTACT INFORMATION

CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs

VAMC Providence

830 Chalkstone Avenue Providence RI 02908

POINT OF CONTACT*

Contract Specialist Michael Kaplan michael.kaplan2@va.gov

(401) 273-7100 None None

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

NOTICE OF INTENT TO SOLE SOURCE

This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source Purchase Order contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services will Satisfy Agency Requirements.

Market Research: The Department of Veterans Affairs, Network Contracting Office 1 New England, Regional Procurement Office East on Behalf of Boston Healthcare System requires Synergy XD drug coated bioabsorbable polymer stents for their Cardiac Cath Lab. The Synergy XD has been shown to minimize the processes leading to restenosis within the stented segment of artery, such as inflammation, neoatherosclerosis and late stent thrombosis, a life threatening condition. The Synergy XD is also the only stent available in a 48mm length. This stent will replace the current Synergy stent. It is a more deliverable, particularly from the radial approach. The stent is better designed for strength and flexibility. Very low profile with extended lubricious coating which increases trackability by reducing friction particularly in very tortuous anatomy. Large Business OEM Boston Scientific Corporation is the sole manufacturer of this product. The procurement of this product will additionally ensure standardization of current compatible equipment. Conversations with Boston Scientific representatives who verified and provided written documentation indicating that they were the only source of these products and that they do not sell through any distributors. Recent reviews of similar awards confirm that Boston Scientific provides all Boston Scientific products directly. Rule of 2 not met due to the medical specific nature of the items. The Department of Veterans Affairs, Network Contracting Office 1 New England, Regional Procurement Office East intends to purchase Synergy XD heart stents on behalf of Boston Healthcare System. This purchase order will be a sole source award to Boston Scientific Corporation on or about 5 November 2021. The North American Industry Classification System (NAICS) code for this requirement is: 339112 – Surgical and Medical Instrument Manufacturing. The Size Standard for this NAICS code is 1,000 Employees.

This notice is not a request for proposals or quote. However, all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.

Interested vendors must respond to this notice on or before November 4, 2021, at 12:00 pm Eastern Standard Time to Michael.Kaplan2@va.gov and Cory.Dionne@va.gov. Please be sure to address both parties above on any and all responses.

Presolicitation Notice Presolicitation Notice

*=Required Field
Presolicitation Notice

Presolicitation Notice

DEPARTMENT OF VETERANS AFFAIRS

Justification for Single Source Awards IAW FAR 13.106-1 For Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)

Acquisition Plan Action ID: Boston Scientific Synergy XD

1. Contracting Activity: Department of Veterans Affairs, Network Contracting Office 1 New England, Regional Procurement Office East on behalf of Boston Healthcare System.

2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount:

Scientific Synergy XD, for the Cardiac Cath lab.

$111,350.00

3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used: The Synergy XD is a drug coated bioabsorbable polymer stent which has been shown to minimize the processes leading to restenosis within the stented segment of artery, such as inflammation, neoatherosclerosis and late stent thrombosis, a life threatening condition. The Synergy XD is also the only stent available in a 48mm length. This is particularly important as the longer length negates the need of 2 or more stents being placed, with areas of overlap which have higher incidence of stent thrombosis.

This product is manufactured by Boston Scientific Corporation.

OEM LB Boston Scientific Corporation

NAICS: 02-171-7889

300 Boston Scientific Way, Marlborough W

4. Description of market research conducted and results or statement why it was not conducted:

Standardization of current compatible equipment. Rule of 2 NOT met due to the particular nature of the items.

This stent will replace the current Synergy stent. It is a more deliverable, particularly from the radial approach. The stent is better designed for strength and flexibility. Very low profile with extended lubricious coating which increases trackability by reducing friction particularly in very tortuous anatomy. OEM LB Boston Scientific Corporation is the sole manufacturer of this product.

Conversations with Boston Scientific representatives who verified and provided written documentation indicating that they were the only source of these products and that they do not sell through any distributors. Recent reviews of similar awards confirm that Boston Scientific provides all Boston Scientific products directly.

Contracting Officer's Certification: Purchase is approved in accordance with FAR13.106-1(b). I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.

VHAPM Part 813.106 Page 4 of 4 Original Date: 08/30/17 Revision 02 Eff Date: 03/31/2020 image1.png

File details come from the government source that posted it. Updated .